NCT05908708 Closed-loop Medtronic 780G System in Youth With Type 1 Diabetes
| NCT ID | NCT05908708 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sheba Medical Center |
| Condition | Type 1 Diabetes |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2023-06-01 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2023-06-01 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to describe data on Israeli children and youth using the 780G system including data regarding glycemic control parameters, various questionnaires, sleep data, bioimpedance measures, and dietary parameters. The main questions it aims to answer are: • whether the 780G system will improve glycemic control • whether the psychosocial aspects will improve. Participants will be followed once connected to 780G, at baseline, one, three, six months, 1 year, and two years after the connection.
Eligibility Criteria
Inclusion Criteria: Diagnosis of type 1 diabetes Diabetes duration ≥ 6 months Routine attendance at clinic visits Initiation of 780G system usage Exclusion Criteria: Children under the age of 1 year Children without 780G system
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05908708 clinical trial?
This trial is open to participants of all sexes, aged 1 Year or older, up to 21 Years, studying Type 1 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05908708 currently recruiting?
Yes, NCT05908708 is actively recruiting participants. Contact the research team at noah.gruber@sheba.health.gov.il for enrollment information.
Where is the NCT05908708 trial being conducted?
This trial is being conducted at Ramat Gan, Israel.
Who is sponsoring the NCT05908708 clinical trial?
NCT05908708 is sponsored by Sheba Medical Center. The trial plans to enroll 120 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.